Analyst Ratings Coverage Update: May 6th 2025

Analyst Ratings

The overall analyst sentiment from today’s analyst coverage updates is “Neutral” to “Slightly Bearish”, with pockets of optimism in select company names.

Here are the latest analyst updates:

AECOM (ACM) had its target price raised by Robert W. Baird from $108.00 to $118.00 while maintaining an Outperform rating.

Affirm Holdings (AFRM) had its target price lowered by Morgan Stanley from $65.00 to $60.00 while maintaining an Equal Weight rating.

Aflac (AFL) had its target price raised by Wells Fargo & Company from $102.00 to $103.00 while maintaining an Equal Weight rating.

Air Canada (AC:CA) had its target price lowered by Raymond James from $28.00 to $24.00 while maintaining a Market Perform rating.

Albemarle (ALB) had its target price lowered by Bank of America from $68.00 to $58.00, maintaining an Underweight rating.

Albemarle (ALB) also had its target price lowered by Citigroup from $80.00 to $60.00 while maintaining a Neutral rating.

Allison Transmission (ALSN) had its target price raised by Morgan Stanley from $94.00 to $100.00 while maintaining an Equal Weight rating.

Allstate (ALL) had its target price lowered by Wells Fargo & Company from $200.00 to $197.00 while maintaining an Equal Weight rating.

Allstate (ALL) also had its target price raised by Jefferies Financial Group from $225.00 to $235.00 while maintaining an Overweight rating.

Alphabet Inc. (GOOGL) had its rating reiterated by JMP Securities as Market Perform.AMC Networks (AMCX) had its target price lowered by JPMorgan Chase & Co. from $8.00 to $6.00 while maintaining an Underweight rating.

Ameren (AEE) had its target price raised by Barclays from $101.00 to $104.00 while maintaining an Equal Weight rating.

Ameresco (AMRC) had its target price raised by Craig Hallum from $27.00 to $29.00 while maintaining a Buy rating.

Ameresco (AMRC) also had its target price set by Evercore ISI at $21.00 while maintaining an Overweight rating.

American Eagle Outfitters (AEO) had its target price lowered by Morgan Stanley from $12.00 to $11.00 while maintaining an Equal Weight rating.

American International Group (AIG) had its target price raised by Morgan Stanley from $80.00 to $81.00 while maintaining an Equal Weight rating.

AnaptysBio (ANAB) had its target price raised by Guggenheim from $52.00 to $54.00 while maintaining a Buy rating.

Andersons (ANDE) had its rating initiated by BMO Capital Markets with a Market Perform rating and a price target of $45.00.

Angel Oak Mortgage REIT (AOMR) had its rating reiterated by Jones Trading as Buy with a price target of $10.50.

AptarGroup (ATR) had its rating reiterated by Wells Fargo & Co. as Overweight with a price target raised from $162.00 to $170.00.

Ares Capital (ARCC) had its target price lowered by Royal Bank of Canada from $24.00 to $23.00 while maintaining an Outperform rating.

Ares Management (ARES) had its target price raised by Barclays from $142.00 to $182.00 while maintaining an Overweight rating.

Ares Management (ARES) also had its target price raised by Wells Fargo & Co. from $156.00 to $182.00 while maintaining an Overweight rating.

Artisan Partners Asset Management (APAM) had its target price raised by Royal Bank of Canada from $43.00 to $44.00 while maintaining an Outperform rating.

Artivion (AORT) had its rating reiterated by Needham & Company LLC as Buy with a price target of $32.00.

Artivion (AORT) also had its rating reiterated by JMP Securities as Market Outperform with a price target of $33.00.

Ashland (ASH) had its target price lowered by JPMorgan Chase & Co. from $71.00 to $67.00 while maintaining an Overweight rating.

AXIS Capital (AXS) had its target price raised by Wells Fargo & Co. from $100.00 to $104.00 while maintaining an Equal Weight rating.

Axsome Therapeutics (AXSM) had its rating reiterated by Wells Fargo & Co. as Overweight with a price target raised from $160.00 to $165.00.

Axsome Therapeutics (AXSM): Robert W. Baird raised the target price to $162.00 from $160.00, maintaining an “Outperform” rating.

Bank First (BFC): Hovde Group upgraded the rating to “Outperform” from “Market Perform,” setting a target price of $130.00.

Barrett Business Services (BBSI): Barrington Research reiterated the “Outperform” rating, keeping the target price at $45.00.

Bath & Body Works (BBWI): Morgan Stanley lowered the target price to $43.00 from $49.00, maintaining an “Overweight” rating.

Bausch + Lomb (BLCO): Morgan Stanley reduced the target price to $12.00 from $18.00, keeping the “Equal Weight” rating.

Baytex Energy Corp. (BTE:CA): Raymond James, TD Securities, and National Bank all lowered their target prices to $3.50, $4.50, and $5.00, respectively, while maintaining their ratings of “Market Perform,” “Buy,” and “Outperform.”

Becton, Dickinson and Company (BDX): Morgan Stanley lowered the target price to $196.00 from $280.00, maintaining the “Overweight” rating.

BioCryst Pharmaceuticals (BCRX): JPMorgan Chase & Co. and Needham & Company raised the target price to $13.00 from $10.00 and to $17.00 from $15.00, respectively, maintaining an “Overweight” and “Buy” rating.

Biomea Fusion (BMEA): D. Boral Capital and HC Wainwright reiterated the “Buy” rating, with the target price unchanged at $16.00 and $18.00, respectively.

BioNTech (BNTX): Morgan Stanley lowered the target price to $132.00 from $140.00, maintaining the “Overweight” rating. Citigroup reiterated the “Buy” rating, lowering the target price to $140.00 from $145.00.

Bright Horizons Family Solutions (BFAM): Morgan Stanley raised the target price to $106.00 from $100.00, maintaining the “Underweight” rating.

Broadridge Financial Solutions (BR): Needham & Company initiated a “Buy” rating with a target price of $300.00.

Builders Capital Mortgage Corp (BCF:CA): Fundamental Research initiated a “Buy” rating with a target price of $9.92.

Burlington Stores (BURL): Morgan Stanley lowered the target price to $269.00 from $297.00, maintaining the “Overweight” rating.

Cable One (CABO): JPMorgan Chase & Co. lowered the target price to $222.00 from $325.00, maintaining the “Neutral” rating.

Cactus (WHD): JPMorgan Chase & Co. lowered the target price to $52.00 from $54.00, maintaining the “Neutral” rating.

Canaan (CAN): Benchmark initiated a “Buy” rating with a target price of $3.00.

Canadian National Railway (CNI): Susquehanna upgraded the rating to “Positive” from “Neutral,” setting a target price of $120.00.

Castle Biosciences (CSTL): Canaccord Genuity Group lowered the target price to $37.00 from $42.00, maintaining the “Buy” rating.

Cedar Fair (FUN): Morgan Stanley lowered the target price to $47.00 from $58.00, maintaining the “Overweight” rating.

Celldex Therapeutics (CLDX): HC Wainwright reiterated the “Buy” rating, with the target price unchanged at $80.00.

Certara (CERT): JMP Securities reiterated the “Market Perform” rating, with no target price change.

Chevron (CVX): DZ Bank downgraded the rating to “Sell” from “Buy,” setting a target price of $130.00.

Church & Dwight (CHD): TD Cowen downgraded the rating to “Hold” from “Buy,” setting a target price of $100.00.

Clorox (CLX): Wells Fargo & Company, JPMorgan Chase & Co., and Morgan Stanley lowered the target prices to $142.00, $144.00, and $150.00, respectively, maintaining the “Equal Weight,” “Neutral,” and “Equal Weight” ratings.

Coinbase Global (COIN): Monness Crespi & Hardt downgraded the rating to “Neutral” from “Buy,” with no target price change.

Comcast (CMCSA): Argus downgraded the rating to “Hold” from “Buy,” with no target price change.

Conagra Brands (CAG): JPMorgan Chase & Co. lowered the target price to $25.00 from $26.00, maintaining the “Neutral” rating.

Controladora Vuela Compañía de Aviación (VLRS): JPMorgan Chase & Co. lowered the target price to $7.00 from $13.00, maintaining the “Overweight” rating.

Corcept Therapeutics (CORT): HC Wainwright lowered the target price to $145.00 from $150.00, maintaining the “Buy” rating.

Corebridge Financial (CRBG): Barclays raised the target price to $38.00 from $36.00, maintaining the “Overweight” rating.

CorMedix (CRMD): D. Boral Capital reiterated the “Buy” rating, with no target price change.

Coterra Energy (CTRA): Barclays lowered the target price to $35.00 from $37.00, maintaining the “Overweight” rating.

CT REIT (CRT.UN:CA): Scotiabank raised the target price to $16.50 from $16.00, maintaining the “Outperform” rating.

Cummins (CMI): JPMorgan Chase & Co. raised the target price to $320.00 from $308.00, maintaining the “Neutral” rating. Morgan Stanley raised the target price to $350.00 from $340.00, maintaining the “Overweight” rating.

CVS Health (CVS): Wells Fargo & Company reiterated the “Overweight” rating, raising the target price to $84.00 from $76.00.

Denny’s (DENN): Oppenheimer lowered the target price to $6.00 from $7.00, maintaining the “Outperform” rating.

Diamondback Energy (FANG): Evercore ISI initiated an “Outperform” rating with a target price of $165.00.

FrontView REIT, Inc. (FVR): Bank of America downgraded the stock from Buy to Neutral with a price target of $15.00.

Fulgent Genetics (FLGT): Piper Sandler reiterated a Neutral rating on the stock.

GAP (GAP): Morgan Stanley lowered the target price from $30.00 to $27.00, maintaining an Overweight rating.

GE HealthCare Technologies (GEHC): Morgan Stanley lowered the target price from $86.00 to $78.00, maintaining an Equal Weight rating.

Genius Sports (GENI): Needham & Company LLC reiterated a Buy rating with a price target of $13.00.

Glaukos Co. (GKOS): Morgan Stanley lowered the target price from $110.00 to $72.00, maintaining an Underweight rating.

Globe Life Inc. (GL): Wells Fargo & Company lowered the target price from $140.00 to $139.00, maintaining an Overweight rating.

GoDaddy (GDDY): JPMorgan Chase & Co. raised the target price from $231.00 to $240.00, maintaining an Overweight rating.

Gray Television, Inc. (GTN): Benchmark lowered the target price from $8.00 to $7.00, maintaining a Buy rating.

Green Impact Partners Inc. (GIP:CA): Canaccord Genuity downgraded the stock from Speculative Buy to Hold, lowering the price target from $6.00 to $3.00.

Guardant Health, Inc. (GH): Piper Sandler reiterated an Overweight rating with no target price provided.

Haleon plc (HLN): Barclays reiterated an Overweight rating with no target price provided.

Harmony Biosciences Holdings, Inc. (HRMY): Needham & Company LLC reiterated a Buy rating with a price target of $49.00.

HBT Financial, Inc. (HBT): Hovde Group upgraded the stock from Market Perform to Outperform with a price target of $28.00.

Henry Schein, Inc. (HSIC): Wells Fargo & Company lowered the target price from $80.00 to $75.00, maintaining an Equal Weight rating.

Hims & Hers Health, Inc. (HIMS): Citigroup reiterated a Sell rating with a price target raised from $25.00 to $30.00.

Hydro One Ltd. (H:CA): Desjardins Securities initiated a Buy rating with a price target of $58.00.

Ichor Holdings, Ltd. (ICHR): TD Cowen lowered the target price from $38.00 to $28.00, maintaining a Buy rating.

Immuneering Co. (IMRX): Chardan Capital reiterated a Buy rating with a price target of $13.00.

Imperial Oil Ltd. (IMO:CA): Desjardins Securities raised the target price from $85.00 to $89.00, maintaining a Hold rating.

Inspire Medical Systems, Inc. (INSP): Wells Fargo & Company lowered the target price from $195.00 to $174.00, maintaining an Equal Weight rating.

Integra LifeSciences Holdings Co. (IART): JPMorgan Chase & Co. lowered the target price from $24.00 to $12.00, maintaining an Underweight rating.

Invitation Homes Inc. (INVH): Oppenheimer raised the target price from $39.00 to $41.00, maintaining an Outperform rating.

James River Group Holdings, Ltd. (JRVR): JMP Securities reiterated a Market Outperform rating with a price target of $8.00.

Janus Henderson Group plc (JHG): Morgan Stanley raised the target price from $32.00 to $33.00, maintaining an Equal Weight rating.

Kinder Morgan, Inc. (KMI): JPMorgan Chase & Co. raised the target price from $29.00 to $30.00, maintaining a Neutral rating.

Laboratory Co. of America Holdings (LH): Piper Sandler reiterated a Neutral rating with no target price provided.

Lakeland Financial (LKFN): Hovde Group upgraded the stock from Market Perform to Outperform with a price target of $72.00.

Lattice Semiconductor Co. (LSCC): Several analysts raised target prices, with TD Cowen increasing it from $50.00 to $58.00, Benchmark maintaining a $60.00 target, and Needham & Company LLC reiterating a Buy rating with a price target of $70.00.

Leonardo DRS (DRS): Morgan Stanley raised the target price from $34.00 to $44.00, maintaining an Equal Weight rating.

Liberty Global Ltd. (LBTYA): Barclays maintained an Equal Weight rating with a target price lowered from $12.00 to $11.00.

Lincoln Electric Holdings, Inc. (LECO): Morgan Stanley raised the target price from $179.00 to $180.00, maintaining an Underweight rating.

Lineage, Inc. (LINE): Bank of America downgraded the stock from Buy to Neutral, raising the price target from $43.00 to $49.00.

Logitech International S.A. (LOGI): Loop Capital lowered the target price from $97.00 to $78.00, maintaining a Hold rating.

Lowe’s Companies, Inc. (LOW): JPMorgan Chase & Co. lowered the target price from $300.00 to $263.00, maintaining an Overweight rating.

Macy’s, Inc. (M): Morgan Stanley lowered the target price from $14.00 to $12.00, maintaining an Equal Weight rating.

Madison Square Garden Sports Corp. (MSGS): Guggenheim reiterated a Buy rating with a price target of $314.00.

MARA Holdings, Inc. (MARA): Compass Point downgraded the stock from Neutral to Sell with a price target lowered from $25.00 to $9.50.

Martin Marietta Materials, Inc. (MLM): Morgan Stanley raised the target price from $561.00 to $576.00, maintaining an Overweight rating.

Matson, Inc. (MATX): Jefferies Financial Group reiterated a Buy rating with a price target of $125.00, while Stephens lowered the target price from $175.00 to $150.00, maintaining an Overweight rating.

Mattel, Inc. (MAT): Morgan Stanley raised the target price from $16.00 to $17.00, maintaining an Equal Weight rating.

McDonald’s Co. (MCD): Northcoast Research downgraded the stock from Buy to Neutral, with no price target provided.

Mercer International Inc. (MERC): CIBC World Markets lowered the target price to $6.00, maintaining a Neutral rating.

MetLife, Inc. (MET): Wells Fargo & Company raised the target price from $91.00 to $94.00, maintaining an Overweight rating.

Mohawk Industries, Inc. (MHK): JPMorgan Chase & Co. lowered the target price from $156.00 to $139.00, maintaining an Overweight rating.

monday.com Ltd. (MNDY): JPMorgan Chase & Co. lowered the target price from $400.00 to $350.00, maintaining an Overweight rating.

Napco Security Technologies, Inc. (NSSC): Needham & Company LLC lowered the target price from $37.00 to $32.00, maintaining a Buy rating.

National Grid plc (NGG): Citigroup reiterated a Buy rating with no target price provided.

Navitas Semiconductor Co. (NVTS): Needham & Company LLC lowered the target price from $4.00 to $3.00, maintaining a Buy rating.

Neurocrine Biosciences, Inc. (NBIX): Multiple analysts raised target prices, including UBS Group raising it from $137.00 to $152.00, while Guggenheim raised it from $155.00 to $165.00, maintaining Buy ratings.

Nexstar Media Group, Inc. (NXST) had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $215.00, down from $225.00.

NIKE, Inc. (NKE) saw its price target lowered by Telsey Advisory Group, keeping a Market Perform rating with a new target of $70.00, down from $80.00.

Norwegian Cruise Line Holdings Ltd. (NCLH) had its price target lowered by Morgan Stanley, maintaining an Equal Weight rating with a new target of $20.00, down from $21.00.

Ocular Therapeutix, Inc. (OCUL) saw its price target lowered by Needham & Company LLC, maintaining a Buy rating with a new target of $14.00, down from $15.00.

Olin Co. (OLN) had its price target raised by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $22.00, up from $19.00.

Olin Co. (OLN) had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $20.00, down from $28.00.

Olympic Steel (ZEUS) had its price target lowered by KeyCorp, maintaining an Overweight rating with a new target of $41.00, down from $43.00.

Onsemi (ON) had its price target raised by TD Cowen, maintaining a Buy rating with a new target of $44.00, up from $38.00.

Onsemi (ON) had its price target reiterated by Rosenblatt Securities, maintaining a Neutral rating with no change to the target of $42.00.

Onsemi (ON) had its price target lowered by Robert W. Baird, maintaining a Neutral rating with a new target of $34.00, down from $42.00.

Onsemi (ON) had its price target lowered by Needham & Company LLC, maintaining a Buy rating with a new target of $50.00, down from $57.00.

Onsemi (ON) had its price target lowered by Wells Fargo & Company, maintaining an Overweight rating with a new target of $45.00, down from $60.00.

Onsemi (ON) had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $48.00, down from $60.00.

Onsemi (ON) had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $50.00, down from $60.00.

Orbia Advance Co., S.A.B. de C.V. (MXCHY) had its rating reiterated by Barclays with an Overweight rating and no change to the target.

Palantir Technologies Inc. (PLTR) had its price target raised by Mizuho, maintaining an Underperform rating with a new target of $94.00, up from $80.00.

Palantir Technologies Inc. (PLTR) had its price target raised by Morgan Stanley, maintaining an Equal Weight rating with a new target of $98.00, up from $90.00.

Palantir Technologies Inc. (PLTR) had its price target raised by Cantor Fitzgerald, maintaining a Neutral rating with a new target of $110.00, up from $98.00.

Palantir Technologies Inc. (PLTR) had its price target raised by UBS Group, maintaining a Neutral rating with a new target of $110.00, up from $105.00.

Palantir Technologies Inc. (PLTR) had its rating reiterated by Deutsche Bank AG, maintaining a Sell rating.

Palantir Technologies Inc. (PLTR) had its price target set by Wedbush, maintaining an Outperform rating with a target of $140.00.

Parkland Corp. (PKI:CA) had its price target raised by National Bank, with a new target of $42.00, up from $41.00.

Parkland Corp. (PKI:CA) had its price target lowered by TD Securities, changing from a Buy rating to a Sell rating with a new target of $44.00, down from $50.00.

Parkland Corp. (PKI:CA) had its price target lowered by Scotiabank, maintaining an Outperform rating with a new target of $44.00, down from $52.00.

Paymentus Holdings, Inc. (PAY) had its price target raised by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $35.00, up from $29.00.

Paymentus Holdings, Inc. (PAY) had its price target raised by Robert W. Baird, maintaining an Outperform rating with a new target of $36.00, up from $30.00.

Pinterest, Inc. (PINS) had its price target lowered by Benchmark, maintaining a Buy rating with a new target of $45.00, down from $55.00.

PRA Group, Inc. (PRAA) had its price target lowered by JMP Securities, maintaining a Market Outperform rating with a new target of $23.00, down from $30.00.

Premium Brands Holdings Corp. (PBH:CA) had its price target lowered by RBC Capital, maintaining a Sector Perform rating with a new target of $97.00, down from $98.00.

Principal Financial Group (PFG) had its price target raised by Morgan Stanley, maintaining an Underweight rating with a new target of $67.00, up from $65.00.

Prudential Financial, Inc. (PRU) had its price target raised by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $113.00, up from $108.00.

Quanta Services, Inc. (PWR) had its price target set by Piper Sandler, maintaining an Overweight rating with a target of $360.00.

Quest Diagnostics (DGX) had its price target raised by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $190.00, up from $180.00.

ServiceNow, Inc. (NOW) had its price target reiterated by Oppenheimer, maintaining an Outperform rating with a new target of $1,100.00, up from $970.00.

ServiceNow, Inc. (NOW) had its price target reiterated by Needham & Company LLC, maintaining a Buy rating with a target of $1,050.00.

ServiceNow, Inc. (NOW) had its price target reiterated by JMP Securities, maintaining a Market Outperform rating with a target of $1,300.00.

Shopify Inc. (SHOP:CA) had its price target lowered by ATB Capital, maintaining a Sector Perform rating with a new target of $120.00, down from $170.00.

Shopify Inc. (SHOP) had its price target set by BMO Capital Markets, maintaining an Outperform rating with a target of $120.00 USD.

Tenaris (TS) had its price target set by Barclays, maintaining an Overweight rating with a new target of $48.00, down from $50.00.

The Gap, Inc. (GAP) had its price target lowered by Morgan Stanley, maintaining an Overweight rating with a new target of $27.00, down from $30.00.

The Home Depot, Inc. (HD) had its price target lowered by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $410.00, down from $470.00.

The Marcus Co. (MCS) had its rating reiterated by Barrington Research, maintaining an Outperform rating with a target of $25.00.

TransAlta Corp. (TA:CA) had its price target lowered by Desjardins Securities, maintaining a Hold rating with a new target of $14.00, down from $16.00.

TVA Group Inc (TVA.B:CA) had its rating downgraded by National Bank from Sector Perform to Underperform with a new target of $0.25, down from $1.00.

Twist Bioscience (TWST) had its price target lowered by JPMorgan Chase & Co., maintaining an Underweight rating with a new target of $33.00, down from $40.00.

Twist Bioscience (TWST) had its rating reiterated by Guggenheim, maintaining a Buy rating with no change to the target of $50.00.

Twist Bioscience (TWST) had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $44.00, down from $54.00.

Tyson Foods (TSN) had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $61.00, down from $63.00.

Tyson Foods (TSN) had its price target lowered by Stephens, maintaining an Equal Weight rating with a new target of $61.00, down from $63.00.

United Parks & Resorts Inc. (PRKS) had its price target lowered by Morgan Stanley, maintaining an Equal Weight rating with a new target of $50.00, down from $56.00.

Upwork (UPWK) had its price target reiterated by Needham & Company LLC, maintaining a Buy rating with no change to the target of $19.00.

Upwork (UPWK) had its price target lowered by Citigroup, maintaining a Neutral rating with a new target of $18.00, down from $19.00.

Urban Outfitters (URBN) had its price target lowered by Morgan Stanley, maintaining an Overweight rating with a new target of $62.00, down from $63.00.

Veralto (VLTO) had its rating initiated by Northcoast Research, maintaining a Buy rating with a target of $110.00.

Vertex Pharmaceuticals (VRTX) had its price target raised by Morgan Stanley, maintaining an Equal Weight rating with a new target of $464.00, up from $462.00.

Vertex Pharmaceuticals (VRTX) had its price target raised by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $515.00, up from $512.00.

Vertex Pharmaceuticals (VRTX) had its rating reiterated by Cantor Fitzgerald, maintaining an Overweight rating with a target of $535.00.

Vertex Pharmaceuticals (VRTX) had its rating reiterated by Leerink Partners, upgrading its rating from Market Perform to Outperform with a new target of $503.00.

Vertex Pharmaceuticals (VRTX) had its rating reiterated by Needham & Company LLC, maintaining a Hold rating with no change to the target.

Vimeo (VMEO) had its price target set by Piper Sandler, maintaining an Overweight rating with a target of $8.00.

Wajax Corp (WJX:CA) had its price target raised by BMO Capital Markets, with a new target of $22.00, up from $20.00.

Waldencast (WALD) had its rating reiterated by Telsey Advisory Group, maintaining an Outperform rating with a target of $5.00.

Walmart (WMT) had its rating reiterated by Royal Bank of Canada, maintaining an Outperform rating with no change to the target of $102.00.

Wendy’s (WEN) had its price target lowered by BMO Capital Markets, maintaining a Market Perform rating with a new target of $15.00, down from $17.00.

Westlake (WLK) had its price target lowered by JPMorgan Chase & Co., maintaining a Neutral rating with a new target of $82.00, down from $110.00.

Westlake (WLK) had its price target lowered by Wells Fargo & Company, maintaining an Overweight rating with a new target of $95.00, down from $110.00.

Westlake (WLK) had its price target lowered by BMO Capital Markets, maintaining a Market Perform rating with a new target of $103.00, down from $125.00.

Westrock Coffee (WEST) had its rating reiterated by Telsey Advisory Group, maintaining an Outperform rating with a target of $9.00.

Westshore Terminals Investment Corp. (WTE:CA) had its price target lowered by RBC Capital, maintaining a Sector Perform rating with a new target of $23.00, down from $25.00.

Wolverine World Wide (WWW) had its price target raised by Robert W. Baird, maintaining an Outperform rating with a new target of $20.00, up from $15.00.

Workday (WDAY) had its rating initiated by Westpark Capital with a Buy rating and a target of $315.00.

Wyndham Hotels & Resorts (WH) had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $99.00, down from $107.00.

Yorkton Equity Group Inc (YEG:CA) had its rating initiated by Fundamental Research, maintaining a Buy rating with a target of $0.34.

Zimmer Biomet (ZBH) had its price target lowered by Wells Fargo & Company, maintaining an Equal Weight rating with a new target of $98.00, down from $113.00.

Zimmer Biomet (ZBH) had its price target lowered by JPMorgan Chase & Co., maintaining an Overweight rating with a new target of $105.00, down from $128.00.

Zimmer Biomet (ZBH) had its price target lowered by Robert W. Baird, maintaining an Outperform rating with a new target of $115.00, down from $130.00.

Zimmer Biomet (ZBH) had its price target updated by Stifel Nicolaus, maintaining a target of $115.00.